Versigent PLC (VGNT) SEC Filings, Jun-Sep 2026

Versigent PLC (symbol: VGNT) is the issuer of record for a Form 4 filing submitted to the SEC. Acosta Janis N reported acquisition or exercise transactions in this Form 4 filing.

Versigent PLC (VGNT) reported that its CLO and Secretary, Janis N. Acosta, received an award of 113.023 dividend equivalent rights on September 18, 2026. These rights accrued on her restricted stock units due to a cash dividend and are the economic equivalent of 113.023 ordinary shares, vesting on the same schedule as the related units. After this award, she directly holds 113.023 dividend equivalent rights, and no Rule 10b5-1 trading plan is reported for this transaction.

Versigent PLC (VGNT) director Kevin P. Clark reported open-market sales of a total of 122,722 Ordinary Shares on September 8–9, 2026, in multiple tranches at weighted average prices between $44.99 and $50.12 per share, as detailed by price ranges in the footnotes.

The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by Clark on June 3, 2026 through his Kevin P. Clark 2002 Revocable Trust. The filing does not state Clark’s share holdings after these sales.

Versigent PLC (VGNT) has a planned secondary sale of common stock by an affiliate. A total of 220,000 shares of Versigent common stock, with an aggregate market value of $10,425,800, are to be sold on the NYSE through Goldman Sachs & Co. LLC on behalf of the Kevin P. Clark 2002 Revocable Trust. The notice states that these sales are made under a selling plan dated June 3, 2026 intended to comply with Rule 10b5-1(c). Versigent had 70,835,265 shares outstanding of common stock at the time referenced.

Versigent PLC, newly separated from Aptiv via an April 1, 2026 Spin-Off, reported solid Q2 2026 results. Net sales were $2,444 million versus $2,206 million a year earlier, with net income attributable to Versigent of $118 million (up from $107 million). Diluted EPS was $1.64, compared with $1.51. For the first six months of 2026, net sales were $4,656 million and diluted EPS was $2.75.

Cash generation remained steady, with $194 million of operating cash flow in the first half of 2026, against $117 million of capital expenditures. The balance sheet changed markedly post-Spin-Off: total debt rose to $2,224 million, including $800 million of 6.125% notes due 2031, $800 million of 6.375% notes due 2034 and a $495 million Term Loan A, helping fund a $1,894 million dividend to Aptiv. Cash and cash equivalents increased to $554 million. Versigent hedges substantial copper and foreign-currency exposure, holding $116 million of derivative assets and $125 million of cash flow hedge gains in accumulated other comprehensive income.

Versigent PLC reported strong results for the quarter ended June 30, 2026, with net sales of $2,444 million, up 10.8% year-over-year, and Adjusted Net Sales Growth of 5%. Net income attributable to Versigent was $118 million, up 10.3%, while diluted EPS was $1.64 and Adjusted Diluted EPS reached $1.92. Adjusted EBITDA rose to $272 million, a 24.8% increase, lifting Adjusted EBITDA margin to 11.1%, 120 basis points higher than a year earlier.

Net cash provided by operating activities was $158 million and Free Cash Flow was $107 million, relatively flat year-over-year despite $22 million of separation-related costs. The Board declared an inaugural quarterly dividend of $0.13 per share, payable September 18, 2026. Management raised and tightened full‑year 2026 net sales guidance to $9,400–$9,600 million and reaffirmed guidance for Adjusted EBITDA of $950–$1,030 million and Free Cash Flow of $200–$300 million. At June 30, 2026 cash was $554 million and long-term debt was $2,071 million.

Vanguard Portfolio Management LLC, together with certain affiliated entities, reports beneficial ownership of common stock of Versigent PLC. The group reports beneficial ownership of 4,267,555 shares, representing 6.01% of Versigent’s common stock as of June 30, 2026.

Vanguard Portfolio Management has sole voting power over 29,992 shares and sole dispositive power over 4,267,555 shares, with no shared voting or dispositive power. The holdings include securities held by Vanguard funds and managed accounts for which Vanguard Portfolio Management or specified affiliates exercise dispositive and/or voting authority. No single other person has an interest in more than 5% of the class through these holdings.

Vanguard Capital Management filed a Schedule 13G reporting a passive ownership stake in Versigent PLC common stock. As of June 30, 2026, Vanguard and certain affiliates beneficially owned 3,870,983 shares, representing 5.46% of the class.

The group held 654,378 shares with sole voting power and had no shared voting power. It reported 3,870,983 shares with sole dispositive power and no shared dispositive power. Vanguard entities and managed accounts have rights to dividends and sale proceeds, and no other single person’s interest exceeds 5% of the class.

BlackRock, Inc. reports beneficial ownership of 10,615,827 shares of VERSIGENT PLC common stock, representing 15.0% of the outstanding class. BlackRock has sole voting power over 10,470,982 shares and sole dispositive power over 10,615,827 shares, with no shared voting or dispositive power.

The disclosure aggregates positions of specified BlackRock business units, excluding other disaggregated units under SEC Release No. 34-39538. One underlying holder, iShares Core S&P Small-Cap ETF, has an interest exceeding five percent of Versigent’s total outstanding common stock.

Versigent PLC director and CEO Joseph T. Liotine reported a routine share disposition tied to equity compensation. The company withheld 21,289 Ordinary Shares at a price of $45.89 per share to cover tax liabilities when restricted stock units vested. This was not an open-market sale. After the withholding, Liotine directly holds 208,864 Ordinary Shares, indicating he retains a substantial equity stake in Versigent.